Diabetes and cancer

Placing the association in perspective

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Purpose of Review: The association of diabetes and cancer has received increased attention as data have emerged to indicate that the type of diabetes treatment may influence the risk of cancer, and that the risk of cancer among diabetic individuals can be reduced by intervention. The association of diabetes and pancreatic cancer is particularly strong, but often misunderstood. Long-standing type 1 diabetes and type 2 diabetes increase the risk for this malignancy, but the cancer can also induce pancreatogenic, or type 3c, diabetes as well. Recent Findings: This review covers the recent findings which help to clarify these relationships, and offers guidance for prevention, early detection, and treatment. Obesity and, separately, diabetes increase the risk of several common malignancies by about two-fold. This risk is reduced by successful treatments. Type 3c diabetes is more common than previously realized, and strategies to differentiate type 3c diabetes from type 2 diabetes, to identify those candidates who will benefit from screening studies, are discussed. Summary: The death rate because of pancreatic and other cancers can be reduced by an aggressive approach to reversing obesity and hyperinsulinemia, achieving good glycemic control in diabetic patients, and identifying at an early timepoint those patients with pancreatogenic diabetes.

Original languageEnglish (US)
Pages (from-to)81-86
Number of pages6
JournalCurrent Opinion in Endocrinology, Diabetes and Obesity
Volume20
Issue number2
DOIs
StatePublished - Apr 2013
Externally publishedYes

Fingerprint

Type 2 Diabetes Mellitus
Neoplasms
Pancreatic Neoplasms
Obesity
Hyperinsulinism
Therapeutics
Mortality

Keywords

  • Cancer
  • Diabetes
  • Metformin
  • Obesity
  • Pancreatic cancer
  • Pancreatic polypeptide
  • Pancreatogenic diabetes

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Nutrition and Dietetics

Cite this

Diabetes and cancer : Placing the association in perspective. / Andersen, Dana.

In: Current Opinion in Endocrinology, Diabetes and Obesity, Vol. 20, No. 2, 04.2013, p. 81-86.

Research output: Contribution to journalArticle

@article{307b37153deb4d93bacc90f48f0d8f2f,
title = "Diabetes and cancer: Placing the association in perspective",
abstract = "Purpose of Review: The association of diabetes and cancer has received increased attention as data have emerged to indicate that the type of diabetes treatment may influence the risk of cancer, and that the risk of cancer among diabetic individuals can be reduced by intervention. The association of diabetes and pancreatic cancer is particularly strong, but often misunderstood. Long-standing type 1 diabetes and type 2 diabetes increase the risk for this malignancy, but the cancer can also induce pancreatogenic, or type 3c, diabetes as well. Recent Findings: This review covers the recent findings which help to clarify these relationships, and offers guidance for prevention, early detection, and treatment. Obesity and, separately, diabetes increase the risk of several common malignancies by about two-fold. This risk is reduced by successful treatments. Type 3c diabetes is more common than previously realized, and strategies to differentiate type 3c diabetes from type 2 diabetes, to identify those candidates who will benefit from screening studies, are discussed. Summary: The death rate because of pancreatic and other cancers can be reduced by an aggressive approach to reversing obesity and hyperinsulinemia, achieving good glycemic control in diabetic patients, and identifying at an early timepoint those patients with pancreatogenic diabetes.",
keywords = "Cancer, Diabetes, Metformin, Obesity, Pancreatic cancer, Pancreatic polypeptide, Pancreatogenic diabetes",
author = "Dana Andersen",
year = "2013",
month = "4",
doi = "10.1097/MED.0b013e32835eddd3",
language = "English (US)",
volume = "20",
pages = "81--86",
journal = "Current Opinion in Endocrinology, Diabetes and Obesity",
issn = "1752-296X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Diabetes and cancer

T2 - Placing the association in perspective

AU - Andersen, Dana

PY - 2013/4

Y1 - 2013/4

N2 - Purpose of Review: The association of diabetes and cancer has received increased attention as data have emerged to indicate that the type of diabetes treatment may influence the risk of cancer, and that the risk of cancer among diabetic individuals can be reduced by intervention. The association of diabetes and pancreatic cancer is particularly strong, but often misunderstood. Long-standing type 1 diabetes and type 2 diabetes increase the risk for this malignancy, but the cancer can also induce pancreatogenic, or type 3c, diabetes as well. Recent Findings: This review covers the recent findings which help to clarify these relationships, and offers guidance for prevention, early detection, and treatment. Obesity and, separately, diabetes increase the risk of several common malignancies by about two-fold. This risk is reduced by successful treatments. Type 3c diabetes is more common than previously realized, and strategies to differentiate type 3c diabetes from type 2 diabetes, to identify those candidates who will benefit from screening studies, are discussed. Summary: The death rate because of pancreatic and other cancers can be reduced by an aggressive approach to reversing obesity and hyperinsulinemia, achieving good glycemic control in diabetic patients, and identifying at an early timepoint those patients with pancreatogenic diabetes.

AB - Purpose of Review: The association of diabetes and cancer has received increased attention as data have emerged to indicate that the type of diabetes treatment may influence the risk of cancer, and that the risk of cancer among diabetic individuals can be reduced by intervention. The association of diabetes and pancreatic cancer is particularly strong, but often misunderstood. Long-standing type 1 diabetes and type 2 diabetes increase the risk for this malignancy, but the cancer can also induce pancreatogenic, or type 3c, diabetes as well. Recent Findings: This review covers the recent findings which help to clarify these relationships, and offers guidance for prevention, early detection, and treatment. Obesity and, separately, diabetes increase the risk of several common malignancies by about two-fold. This risk is reduced by successful treatments. Type 3c diabetes is more common than previously realized, and strategies to differentiate type 3c diabetes from type 2 diabetes, to identify those candidates who will benefit from screening studies, are discussed. Summary: The death rate because of pancreatic and other cancers can be reduced by an aggressive approach to reversing obesity and hyperinsulinemia, achieving good glycemic control in diabetic patients, and identifying at an early timepoint those patients with pancreatogenic diabetes.

KW - Cancer

KW - Diabetes

KW - Metformin

KW - Obesity

KW - Pancreatic cancer

KW - Pancreatic polypeptide

KW - Pancreatogenic diabetes

UR - http://www.scopus.com/inward/record.url?scp=84874946001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874946001&partnerID=8YFLogxK

U2 - 10.1097/MED.0b013e32835eddd3

DO - 10.1097/MED.0b013e32835eddd3

M3 - Article

VL - 20

SP - 81

EP - 86

JO - Current Opinion in Endocrinology, Diabetes and Obesity

JF - Current Opinion in Endocrinology, Diabetes and Obesity

SN - 1752-296X

IS - 2

ER -